Capivasertib
AstraZeneca,Otsuka
['breast', 'capitello,291', 'capitello-291']
nicholas turner, #crukfunded researcher at is presenting his work on the characterisation + management of common adverse events from the phase 3 capitello-291 trial treating patients with #breastcancer: #asco23
We're here to support our broad cancer research community of 4,000 scientists and clinicians. For general Cancer Research UK news & fundraising follow @CR_UK